<DOC>
	<DOCNO>NCT02055456</DOCNO>
	<brief_summary>Decrease blood cell count due deficient bone marrow function , call bone marrow failure , well lung disease , call idiopathic pulmonary fibrosis , cause genetic defect telomere biology gene , eventually cause telomere erosion . These disorder collectively term `` telomeropathies '' . There evidence male hormone may improve blood cell count marrow failure , hormone able stimulate telomerase function hematopoietic cell vitro . We propose study use male hormone patient aplastic anemia pulmonary fibrosis associate defect telomere .</brief_summary>
	<brief_title>Nandrolone Decanoate Treatment Telomeropathies</brief_title>
	<detailed_description>Telomeres repeat nucleotide sequence non-coding DNA end chromosome protective function avoid chromosome recombination fusion . Loss-of-function mutation gene telomerase complex , enzyme responsible maintaining telomere length , associate bone marrow failure , notedly mutation DKC1 gene , detect rare inherited form marrow aplasia , call dyskeratosis congenita . These finding implicate telomerase dysfunction shorten telomere length fail hematopoiesis . In family member probands aplastic anemia , marrow aplasia telomerase mutation also observe associated varying degree cytopenias , IPF and/or cirrhosis . Moreover , patient vary degree cytopenia , significant family history cytopenia , IPF and/or cirrhosis , identify short telomere mutation telomerase complex gene . Additionally , telomere length associate human cancer . In vitro study suggest telomere length could modulate sex hormone . Normal lymphocytes human bone marrow progenitor cell expose androgen increase telomerase activity vitro , individual telomerase mutation ( TERT ) androgens increased telomerase activity.This could explanation hematologic improvement observe aplastic anemia patient treat 40 year ago male hormone . Therefore , hypothesize androgen therapy might modulate telomere attrition vivo ameliorate progression reverse clinical consequence shorten telomere length , propose androgen therapy patient cytopenias and/or IPF short age adjust telomere length , without telomerase gene mutation . The primary biologic endpoint reduction telomere attrition time compare know rate telomere erosion normal individual carry mutation telomerase gene . Secondary endpoint tolerability nandrolone decanoate two year , improvement blood count and/or pulmonary function .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Decanoic acid</mesh_term>
	<mesh_term>Nandrolone decanoate</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Nandrolone phenpropionate</mesh_term>
	<criteria>Peripheral blood leukocyte telomeres short age , first percentile curve base 500 healthy individual 0 100 year , without telomerase gene mutation . AND One follow cytopenia : Anemia ( symptom anemia hemoglobin &lt; 9.5 g/dL , need transfusion &gt; 2 unit pack red blood cells/month least two month , absolute reticulocyte count &lt; 60.000/μL ) . Thrombocytopenia ( platelet count &lt; 30.000/μL &lt; 50.000/μL associate bleeding , megakaryocytes reduction bone marrow ) . Neutropenia ( absolute neutrophil count &lt; 1.000/μL ) . OR Idiopathic pulmonary fibrosis diagnose accord American Thoracic Society ( ATS ) criterion . Terminal disease liver disease , renal , cardiac , neurological , infectious concomitant metabolic state whose gravity prevent ability patient tolerate treatment protocol , probable death within 30 day . People cancer undergo chemotherapy . Pregnancy , desire prevent pregnancy childbearing age . Aplastic Anemia patient indication bone marrow transplantation match donor .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Hormones</keyword>
	<keyword>Androgens</keyword>
	<keyword>Aplastic Anemia</keyword>
	<keyword>Bone Marrow Failure Syndromes</keyword>
	<keyword>Idiopathic Pulmonary Fibrosis</keyword>
	<keyword>Telomere</keyword>
	<keyword>Telomere Shortening</keyword>
</DOC>